Are we self-actualising in pharmacy? This month’s pick of academic papers from Parastou Donyai, chief scientist at the Royal Pharmaceutical Society.…
Early days of Pharmacy First highlight three things we should study This month, our health policy columnist examines the teething problems thrown up in the first few weeks of the Pharmacy First service.…
More than 5,000 patients treated for ear problems under community pharmacy pilot During a pilot, 20 community pharmacies in south west London offered hearing assessments, screenings and earwax removal.…
All forms of exercise effective in treating depression, meta-analysis finds Researchers concluded that exercise appeared to be equally effective for patients with different levels of depression.…
No government-funded medical cannabis clinical trials ongoing, NIHR confirms The National Institute for Health and Care Research said two trials relating to the use of cannabis for epilepsy are yet to begin.…
First-in-class antibiotic provides effective treatment for UTIs, trial results suggest Gepotidacin showed non-inferiority to nitrofurantoin in one trial and superiority in another.…
Erectile dysfunction drugs may reduce Alzheimer’s risk, study suggests Results from a study of more than 260,000 men has suggested those taking erectile dysfunction drugs were 18% less likely to develop Alzheimer's disease than those not taking the drugs.…
Nominate an outstanding early-career pharmacy researcher for OPERA 2024 *Deadline extended* Help us find exceptional early-career researchers making significant contributions to the field of pharmacy for the 2024 award.…
The Pharmaceutical Journal’s Dawn Connelly wins ‘Pharmacy writer of the year’ award This is the second year in a row that a journalist from The Pharmaceutical Journal has been recognised at the Avicenna Media Awards.…
Type 2 diabetes remission achieved in 6% of patients through weight loss alone, study results show Experts have emphasised the importance of individualised treatment, which may include a low-calorie diet.…
